Journal Article

465PInterim baseline characteristics from RIFTOS MKI, a global non-interventional study assessing the use of multikinase inhibitors (MKIs) in the treatment of patients with asymptomatic radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC): A European subgroup analysis

J.W.A. Smit, M.S. Brose, F. Pitoia, C-C. Lin, I. Sugitani, M. Alevizaki, Y. Godbert, J. Aller, R.P. Peeters, K. Pazaitou-Panayiotou, L. Leenhardt, M.M. Fellous, Y. De Sanctis and M. Schlumberger

in Annals of Oncology

Published on behalf of European Society for Medical Oncology

Volume 28, issue suppl_5 Published in print September 2017 | ISSN: 0923-7534
Published online September 2017 | e-ISSN: 1569-8041 | DOI: https://dx.doi.org/10.1093/annonc/mdx368.037
465PInterim baseline characteristics from RIFTOS MKI, a global non-interventional study assessing the use of multikinase inhibitors (MKIs) in the treatment of patients with asymptomatic radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC): A European subgroup analysis

Show Summary Details

Journal Article.  364 words. 

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.